Nucleic Acids On-Demand World-Wide (NOW)

The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours.

The developed platform

should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.
Related Programs

Research and Technology Development

Department Of Defense


Agency: Department of Defense

Office: DARPA - Biological Technologies Office

Estimated Funding: $81,498


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
FedBizOpps Announcement

Additional Information of Eligibility:
All responsible sources capable of satisfying the Government's needs may submit a proposal that shall be considered by DARPA.

See the Eligibility Information section of the BAA for more information.

Full Opportunity Web Address:
https://www.fbo.gov/index?s=opportunity&mode=form&id=e7ed37766897192c136d2d69eb057525&tab=core&_cview=1

Contact:


Agency Email Description:
lstrong@usbr.gov

Agency Email:


Date Posted:
2019-10-16

Application Due Date:


Archive Date:
2020-02-08


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


The Affordable Care Act Medicaid Incentives for Prevention of Chronic Disease Demonstration Project | Research, Treatment and Education Programs on Lyme Disease in the United States | Sexual Assault Services Program | Transition Assistance Program | Nurse Education, Practice and Retention Grants |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders